Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212
Sofia, Bulgaria, 2 October 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that in pursuance of a decision of the General meeting of Holders of Warrants (GMHW) held on 02.06.2023 and decision of the Board of Directors of SOPHARMA AD from a meeting held on 05.06.2023 and based on art. 195 and art. 196 of the Commercial Law (CL), art. 113, para. 2, item 2 of Law on public offering of securities (LPOS) and art.